BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31890880)

  • 1. Survival benefits from concomitant chemoradiotherapy before radical surgery in stage IVA sinonasal mucosal melanoma?
    Hafström A; Brun E; Persson S; Sjövall J; Wahlberg P; Greiff L
    Laryngoscope Investig Otolaryngol; 2019 Dec; 4(6):624-631. PubMed ID: 31890880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of resectable metastatic melanoma (Stage IVA melanoma).
    Feun LG; Gutterman J; Burgess MA; Hersh EM; Mavligit G; McBride CM; Benjamin RS; Richman SP; Murphy WK; Bodey GP; Brown BW; Mountain CF; Leavens ME; Freireich EJ
    Cancer; 1982 Oct; 50(8):1656-63. PubMed ID: 7116298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
    Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
    PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
    Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
    Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equivalent survival in patients with advanced stage IB-II and III-IVA cervical cancer treated by adjuvant surgery following chemoradiotherapy.
    Carcopino X; Houvenaeghel G; Buttarelli M; Esterni B; Tallet A; Goncalves A; Jacquemier J
    Eur J Surg Oncol; 2008 May; 34(5):569-75. PubMed ID: 17531428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal treatment and immune checkpoint inhibition in sinonasal mucosal melanoma: real-world data of a retrospective, single-center study.
    Scherzad A; Stöth M; Meyer TJ; Haug L; Gehrke T; Schilling B; Meierjohann S; Scheich M; Hagen R; Gesierich A; Hackenberg S
    Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4215-4223. PubMed ID: 37272953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sinonasal mucosal melanoma: treatment strategies and survival rates for a rare disease entity : A single center experience and review of literature.
    Andrianakis A; Kiss P; Pomberger M; Wolf A; Thurnher D; Tomazic PV
    Wien Klin Wochenschr; 2021 Nov; 133(21-22):1137-1147. PubMed ID: 33844113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes and patterns of failure of head and neck mucosal melanoma treated with multiple treatment modalities.
    Xu QQ; Lai YZ; Huang ZL; Zeng ZY; Zhang YN; Ou RY; Wu WM; Chen L; Lu LX
    Radiat Oncol; 2021 Jul; 16(1):138. PubMed ID: 34321026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Benefits From Surgery for Stage IVa Head and Neck Squamous Cell Carcinoma: A Multi-institutional Analysis of 1,033 Cases.
    Park JO; Park YM; Jeong WJ; Shin YS; Hong YT; Choi IJ; Kim JW; Woo SH; Kim YS; Chang JW; Kim MS; Jung KY; Ahn SH; Kim CH; Hong KH; Chung PS; Kim YM; Kim SH; Baek SK
    Clin Exp Otorhinolaryngol; 2021 May; 14(2):225-234. PubMed ID: 33081440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France.
    Moya-Plana A; Aupérin A; Obongo R; Baglin A; Ferrand FR; Baujat B; Saroul N; Casiraghi O; Vergez S; Herman P; Janot F; Thariat J; Vérillaud B; de Gabory L;
    Eur J Cancer; 2019 Dec; 123():1-10. PubMed ID: 31670075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma.
    McLean N; Tighiouart M; Muller S
    Oral Oncol; 2008 Nov; 44(11):1039-46. PubMed ID: 18396446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome for sinonasal malignancies: a population-based survey.
    Hafström A; Sjövall J; Persson SS; Nilsson JS; Svensson C; Brun E; Greiff L
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2611-2622. PubMed ID: 34510258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodal and distant metastases in sinonasal mucosal melanoma: A population-based analysis.
    Low CM; Price DL; Moore EJ; Stokken JK; Van Abel KM; Janus JR; Choby G
    Laryngoscope; 2020 Mar; 130(3):622-627. PubMed ID: 31077407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response.
    Ziel E; Hermann G; Sen N; Bonomi P; Liptay MJ; Fidler MJ; Batus M; Warren WH; Chmielewski G; Sher DJ
    J Thorac Oncol; 2015 Oct; 10(10):1475-80. PubMed ID: 26398822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment outcomes and prognosis of mucosal melanoma of the head and neck: 161 cases from a single institution.
    Sun S; Huang X; Gao L; Zhang Y; Luo J; Zhang S; Wang K; Qu Y; Wu R; Liu Q; Xiao J; Xu G; Yi J
    Oral Oncol; 2017 Nov; 74():115-122. PubMed ID: 29103739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
    Setakornnukul J; Thephamongkhol K
    BMC Cancer; 2018 Mar; 18(1):329. PubMed ID: 29587665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
    Balk M; Rupp R; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Traxdorf M; Eckstein M; Speer S; Semrau S; Fietkau R; Iro H; Hecht M; Gostian AO
    BMC Cancer; 2021 Nov; 21(1):1236. PubMed ID: 34794411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma.
    Amit M; Tam S; Abdelmeguid AS; Kupferman ME; Su SY; Raza SM; DeMonte F; Hanna EY
    J Neurol Surg B Skull Base; 2017 Dec; 78(6):512-518. PubMed ID: 29142805
    [No Abstract]   [Full Text] [Related]  

  • 19. Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma.
    Amit M; Tam S; Abdelmeguid AS; Kupferman ME; Su SY; Raza SM; DeMonte F; Hanna EY
    Ann Surg Oncol; 2018 Jun; 25(6):1723-1729. PubMed ID: 29626308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Treatment Outcomes for Locally Advanced Esophageal Cancer: A Single-Institution Experience.
    Sio TT; Wilson ZC; Stauder MC; Bhatia S; Martenson JA; Quevedo JF; Schomas DA; Miller RC
    Am J Clin Oncol; 2016 Oct; 39(5):448-52. PubMed ID: 24879469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.